ZEVRA THERAPEUTICS INC (ZVRA) Institutional Ownership Changes & 13F Activity
ZEVRA THERAPEUTICS INC (ZVRA). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Woodline Partners Lp, Nantahala Capital Management, Llc, Citadel Advisors Llc, Millennium Management Llc, and D. E. Shaw & Co., Inc..
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Buy | +226 | +1.5% | 15,363 | $220.31K | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Sell | -614,532 | -98.1% | 12,167 | $174.47K | Q2 2026 | Sep 02, 2026 |
| California State Teachers Retirement System | Sell | -2,234 | -74.1% | 781 | $11.20K | Q2 2026 | Aug 24, 2026 |
| Nantahala Capital Management, Llc | Sell | -724,460 | -28.7% | 1,797,476 | $25.78M | Q2 2026 | Aug 19, 2026 |
| Mercer Global Advisors Inc | Buy | +10,172 | — | 10,172 | $145.87K | Q2 2026 | Aug 19, 2026 |
| Stonepine Capital Management, Llc | Sell | -221,299 | -46.1% | 258,701 | $3.71M | Q2 2026 | Aug 17, 2026 |
| Woodline Partners Lp | Buy | +1,334,828 | +38.7% | 4,785,771 | $68.63M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Sell | -499,808 | -84.7% | 90,461 | $1.30M | Q2 2026 | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | Buy | +460,492 | +54.4% | 1,306,949 | $18.74M | Q2 2026 | Aug 14, 2026 |
| Qube Research & Technologies Ltd | Buy | +399,024 | +47.4% | 1,241,343 | $17.80M | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +264,389 | — | 264,389 | $3.79M | Q2 2026 | Aug 14, 2026 |
| Jane Street Group, Llc | Sell | -199,454 | -90.2% | 21,604 | $309.80K | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Sell | -197,573 | -26.6% | 545,551 | $7.82M | Q2 2026 | Aug 14, 2026 |
| Hsbc Holdings Plc | Buy | +154,414 | — | 154,414 | $2.24M | Q2 2026 | Aug 14, 2026 |
| Caption Management, Llc | Sell | -135,236 | -53.0% | 120,000 | $1.72M | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Buy | +134,119 | — | 134,119 | $1.92M | Q2 2026 | Aug 14, 2026 |
| Diametric Capital, Lp | Buy | +123,441 | +114.3% | 231,465 | $3.32M | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Buy | +123,397 | +66.1% | 309,979 | $4.45M | Q2 2026 | Aug 14, 2026 |
| 683 Capital Management, Llc | Sell | -120,000 | -12.3% | 855,000 | $12.26M | Q2 2026 | Aug 14, 2026 |
| Aqr Capital Management Llc | Buy | +111,057 | +139.0% | 190,972 | $2.74M | Q2 2026 | Aug 14, 2026 |
| Royce & Associates Lp | Sell | -106,016 | -10.7% | 882,658 | $12.66M | Q2 2026 | Aug 14, 2026 |
| Osaic Holdings, Inc. | Buy | +72,551 | +1137.7% | 78,928 | $1.13M | Q2 2026 | Aug 14, 2026 |
| Caxton Associates Llp | Buy | +70,048 | — | 70,048 | $1.00M | Q2 2026 | Aug 14, 2026 |
| Legal & General Group Plc | Buy | +38,578 | +3.3% | 1,201,668 | $17.23M | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Buy | +30,767 | +117.4% | 56,972 | $816.98K | Q2 2026 | Aug 14, 2026 |
| Tudor Investment Corp Et Al | Sell | -28,051 | -6.3% | 415,058 | $5.95M | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Buy | +22,837 | +14.1% | 184,818 | $2.65M | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Buy | +21,448 | +138.9% | 36,893 | $529.04K | Q2 2026 | Aug 14, 2026 |
| Two Sigma Securities, Llc | Buy | +13,834 | — | 13,834 | $198.38K | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +12,772 | +24.4% | 65,208 | $935.08K | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about ZVRA activity
Which institutional owners are buying ZVRA?
Institutional owners buying ZVRA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in ZVRA activity?
"Buy" means an investor increased their reported position in ZVRA compared to the prior reporting period. This reflects growing exposure to ZEVRA THERAPEUTICS INC (ZVRA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in ZVRA increasing?
Institutional interest in ZVRA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related ZVRA Institutional Insights
- ZVRA Overview
- ZVRA 13F Institutional Holders
- ZVRA Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- ZVRA Insider Trading & SEC Form 4 Activity
- ZVRA Articles
- Top Institutional Investor Stock Rankings